Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Scientific Reports, 2025
Profiling 92 circulating neurobiological proteins identifies novel candidate biomarkers of long-term cognitive outcome after ischemic stroke

Lagging C., Pedersen A., Petzold M. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Angiogenesis, 2025
ApoM-bound S1P acts via endothelial S1PR1 to suppress choroidal neovascularization and vascular leakage

Jung B., Yagi H., Kuo A. et al.

Olink Explore 3072/384OphthalmologyPathophysiologyPlasma

Parkinsonism & Related Disorders, 2025
Plasma proteomic profiling reveals Parkinson's disease-associated proteins: A UK Biobank study

Jiao X., Lu Y., Huang Y. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Communications Medicine, 2025
Proteomics approach identifies aqueous humor biomarkers in retinal diseases

Huang K., Schofield C., Nguy T. et al.

Olink Target 96OphthalmologyPatient StratificationAqueous Humor

Annals of Allergy, Asthma & Immunology, 2025
Proteomic Profiling of Nasal Fluids and Serum for Type 2 Nasal Polyps Diagnosis

Hou Y., Chen C., Li Z. et al.

Olink Target 96Respiratory DiseasesPatient StratificationSerumNasal Fluid

Nature Immunology, 2025
Identification of soluble biomarkers that associate with distinct manifestations of long COVID

Gao Y., Cai C., Adamo S. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

International Journal of Chronic Obstructive Pulmonary Disease, 2025
Plasma Levels of CXCL9 and MCP-3 are Increased in Asthma-COPD Overlap (ACO) Patients

Escamilla-Gil J., Torres-Duque C., Llinás-Caballero K. et al.

Olink Target 96Respiratory DiseasesPatient StratificationPlasma

International Journal of Molecular Sciences, 2025
Significant Associations Between Blood Cell Counts and Plasma Cytokines, Chemokines, and Growth Factors

Eriksson L., Eriksson M., Gordh T. et al.

Olink Target 96HematologyPathophysiologyPlasma

Investigational New Drugs, 2025
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors

Cohen R., Jimeno A., Hreno J. et al.

Olink Target 96OncologyImmunotherapyPathophysiology

Nature Communications, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis

Chitnis T., Qureshi F., Gehman V. et al.

Olink Target 96NeurologyPatient StratificationSerum

Discover Oncology, 2025
Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer

Cao J., Chen S., Wang J. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Neurobiology of Disease, 2025
Proximity extension assay reveals serum inflammatory biomarkers in two amyotrophic lateral sclerosis cohorts

Chen Y., Sun S., Gao N. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationSerum

Biomarker Research, 2025
The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk

Brandão L., Zhang L., Grip A. et al.

Olink Target 96CVDTechnical EvaluationSerum

Brain, 2025
Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination

Abdelhak A., Cordano C., Duncan G. et al.

Olink Explore 3072/384NeurologyPathophysiologySerum

Acta Neuropathologica Communications, 2025
Neutrophil infiltration and microglial shifts in sepsis induced preterm brain injury: pathological insights

Zhu J., He T., Huang Z. et al.

Olink Target 96NeurologyObstetricsPathophysiologyPlasma

Frontiers in Immunology, 2025
Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology

Zhou X., Wang W., Chen L. et al.

Olink Explore 3072/384ObstetricsPatient StratificationPlasma

hLife, 2025
Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine

Zhou C., Sun M., Huang X. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Nature Communications, 2025
Dissecting cross-population polygenic heterogeneity across respiratory and cardiometabolic diseases

Yamamoto Y., Shirai Y., Sonehara K. et al.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

Neuro-Oncology, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma

Wen P., Manzanera A., Duault C. et al.

Olink Target 48OncologyImmunotherapyPathophysiologyPlasma

Cell Reports Medicine, 2025
Cooking methods affect advanced glycation end products and lipid profiles: A randomized cross-over study in healthy subjects

Wellens J., Vissers E., Dumoulin A. et al.

Olink Target 96Nutritional SciencePathophysiologySerum

2703 publications